CEO Interview - 1H24 results
Filed with ASX · · 3 pages · English
Summary by 6ix AI
This filing is an interview with Dr. Sam Hupert, CEO of Pro Medicus, discussing the company's first half results and future outlook. The CEO highlighted record revenue and net profit, emphasizing the strength of their transaction-based business model and recent contract wins. He also mentioned a recent investment in an AI company and the potential for new technologies like Apple Vision Pro in their operations. Overall, the company is optimistic about maintaining its growth trajectory and expanding its market presence.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from Pro Medicus
- PME launches Visage Ease VP for Apple Vision Pro
- AGM Presentation - 2023
- PME signs A$20M, 8-year contract with OHSU
- PME signs AUD$16M, 8-year contract with South Shore Health
- PME signs AUD$140M, 10-year deal with Baylor Scott & White
Later from Pro Medicus
- HY24 Results Presentation
- Cancel - Notification of buy-back - PME
- S&P DJI Announces March 2024 Quarterly Rebalance
- Macquarie Conference May 2024 Presentation
- PME signs five new deals with a combined minimum of A$45M
Follow Pro Medicus into a list and get an email when it puts out news.
Follow Pro Medicus